MoonLake Immunotherapeutics (MLTX) Receivables - Other (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Receivables - Other of $5.8 million for Q1 2026, up 92.87% year-over-year from $3.0 million in Q1 2025, and up 580.4% quarter-over-quarter from $847000.0 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Receivables - Other (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Receivables - Other history runs 6 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- In Q1 2026, Receivables - Other rose 92.87% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $5.8 million (up 92.87% YoY), while the FY2025 annual figure was $4.9 million, up 71.2% from the prior year.
- Receivables - Other for Q1 2026 stood at $5.8 million, up from $847000.0 in the prior quarter.
- The five-year high for Receivables - Other was $5.8 million in Q1 2026, with the low at -$383407.0 in Q4 2022.
- The 5-year median for Receivables - Other is $720755.0 (2023), against an average of $1.5 million.
- Peak annual rise in Receivables - Other reached 971.77% in 2022, while the deepest fall reached 357.71% in 2022.
- MoonLake Immunotherapeutics' Receivables - Other stood at -$383407.0 in 2022, then soared by 187.73% to $336374.0 in 2023, then advanced by 29.62% to $436000.0 in 2024, then soared by 94.27% to $847000.0 in 2025, then jumped by 580.4% to $5.8 million in 2026.
- Business Quant data shows MLTX's Receivables - Other at $5.8 million in Q1 2026, $847000.0 in Q4 2025, and $4.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.56 Mn |
| Jun 30, 2026 | 6.56 Mn |
| Mar 31, 2026 | 5.76 Mn |
| Mar 31, 2026 | 5.76 Mn |
| Dec 31, 2025 | 847,000.00 |
| Dec 31, 2025 | 847,000.00 |
| Sep 30, 2025 | 4.02 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Mar 31, 2025 | 2.99 Mn |
| Dec 31, 2024 | 436,000.00 |
| Dec 31, 2024 | 436,000.00 |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |